Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Multiple Sclerosis

  Free Subscription


Articles published in J Neurol Neurosurg Psychiatry

Retrieve available abstracts of 54 articles:
HTML format
Text format



Single Articles


    October 2017
  1. AZARY S, Schreiner T, Graves J, Waldman A, et al
    Contribution of dietary intake to relapse rate in early paediatric multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2017 Oct 9. pii: jnnp-2017-315936.
    PubMed     Text format     Abstract available


  2. FITZGERALD K
    Diet and disease modification in multiple sclerosis: a nutritional epidemiology perspective.
    J Neurol Neurosurg Psychiatry. 2017 Oct 9. pii: jnnp-2017-316375.
    PubMed     Text format    


  3. MEIJER KA, Eijlers AJC, Geurts JJG, Schoonheim MM, et al
    Staging of cortical and deep grey matter functional connectivity changes in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2017 Oct 6. pii: jnnp-2017-316329.
    PubMed     Text format     Abstract available


    September 2017
  4. GAJOFATTO A, Nourbakhsh B, Benedetti MD, Waubant E, et al
    Performance of 2010 McDonald criteria and 2016 MAGNIMS guidelines in the diagnosis of primary progressive multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2017 Sep 22. pii: jnnp-2017-316911.
    PubMed     Text format    


  5. PATERGNANI S, Castellazzi M, Bonora M, Marchi S, et al
    Autophagy and mitophagy elements are increased in body fluids of multiple sclerosis-affected individuals.
    J Neurol Neurosurg Psychiatry. 2017 Sep 2. pii: jnnp-2017-316234.
    PubMed     Text format    


    August 2017
  6. SPENCER JI, Bell JS, DeLuca GC
    Vascular pathology in multiple sclerosis: reframing pathogenesis around the blood-brain barrier.
    J Neurol Neurosurg Psychiatry. 2017 Aug 31. pii: jnnp-2017-316011.
    PubMed     Text format     Abstract available


  7. CALABRESE M, Pitteri M, Farina G, Bajrami A, et al
    Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events.
    J Neurol Neurosurg Psychiatry. 2017 Aug 26. pii: jnnp-2017-316236.
    PubMed     Text format     Abstract available


  8. CLAFLIN SB, van der Mei IAF, Taylor BV
    Complementary and alternative treatments of multiple sclerosis: a review of the evidence from 2001 to 2016.
    J Neurol Neurosurg Psychiatry. 2017 Aug 2. pii: jnnp-2016-314490.
    PubMed     Text format     Abstract available


  9. KOCH-HENRIKSEN N, Laursen B, Stenager E, Magyari M, et al
    Excess mortality among patients with multiple sclerosis in Denmark has dropped significantly over the past six decades: a population based study.
    J Neurol Neurosurg Psychiatry. 2017;88:626-631.
    PubMed     Text format     Abstract available


  10. GRYTTEN N
    Survival in multiple sclerosis: things have changed.
    J Neurol Neurosurg Psychiatry. 2017;88:618.
    PubMed     Text format    


  11. LASCANO AM, Lalive PH, Hardmeier M, Fuhr P, et al
    Clinical evoked potentials in neurology: a review of techniques and indications.
    J Neurol Neurosurg Psychiatry. 2017;88:688-696.
    PubMed     Text format     Abstract available


    July 2017
  12. ZHOU Y, Graves JS, Simpson S Jr, Charlesworth JC, et al
    Genetic variation in the gene LRP2 increases relapse risk in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2017 Jul 24. pii: jnnp-2017-315971.
    PubMed     Text format     Abstract available


  13. PREZIOSA P, Rocca MA, Mesaros S, Meani A, et al
    Diagnosis of multiple sclerosis: a multicentre study to compare revised McDonald-2010 and Filippi-2010 criteria.
    J Neurol Neurosurg Psychiatry. 2017 Jul 19. pii: jnnp-2017-315863.
    PubMed     Text format    


  14. EISELE P, Szabo K, Alonso A, Ong M, et al
    Lack of T1 hyperintensity in the dentate nucleus after 15 administrations of a macrocyclic contrast agent in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2017 Jul 14. pii: jnnp-2017-316102.
    PubMed     Text format    


    May 2017
  15. TETTEY P, Simpson S, Taylor B, Ponsonby AL, et al
    An adverse lipid profile and increased levels of adiposity significantly predict clinical course after a first demyelinating event.
    J Neurol Neurosurg Psychiatry. 2017;88:395-401.
    PubMed     Text format     Abstract available


    April 2017
  16. RAGONESE P
    Mortality studies for multiple sclerosis: still a useful tool to analyse long-term outcome.
    J Neurol Neurosurg Psychiatry. 2017 Apr 28. pii: jnnp-2017-315591.
    PubMed     Text format    


  17. OKADA K, Kobata M, Sennari Y, Iwanaka Y, et al
    Levels of nitric oxide metabolites in cerebrospinal fluid correlate with cognitive impairment in early stage multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2017 Apr 26. pii: jnnp-2017-315585.
    PubMed     Text format    


  18. LUNDE HB, Assmus J, Kjell-Morten M, Bo L, et al
    Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study.
    J Neurol Neurosurg Psychiatry. 2017 Apr 1. pii: jnnp-2016-315238.
    PubMed     Text format     Abstract available


  19. COMI G, De Stefano N, Freedman MS, Barkhof F, et al
    Subcutaneous interferon beta-1a in the treatment of clinically isolated syndromes: 3-year and 5-year results of the phase III dosing frequency-blind multicentre REFLEXION study.
    J Neurol Neurosurg Psychiatry. 2017;88:285-294.
    PubMed     Text format     Abstract available


    March 2017
  20. MURPHY R, O'Donoghue S, Counihan T, McDonald C, et al
    Neuropsychiatric syndromes of multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2017 Mar 11. pii: jnnp-2016-315367.
    PubMed     Text format     Abstract available


  21. ZALEWSKI NL, Morris PP, Weinshenker BG, Lucchinetti CF, et al
    Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders.
    J Neurol Neurosurg Psychiatry. 2017;88:218-225.
    PubMed     Text format     Abstract available


    February 2017
  22. JURYNCZYK M, Tackley G, Kong Y, Geraldes R, et al
    Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease.
    J Neurol Neurosurg Psychiatry. 2017;88:132-136.
    PubMed     Text format     Abstract available


    December 2016
  23. ROCCA MA, Filippi M
    Modulation of cortical excitability to normalise brain function and improve cognition in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Dec 30. pii: jnnp-2016-315195.
    PubMed     Text format    


  24. HULST HE, Goldschmidt T, Nitsche MA, de Wit SJ, et al
    rTMS affects working memory performance, brain activation and functional connectivity in patients with multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Dec 14. pii: jnnp-2016-314224.
    PubMed     Text format     Abstract available


    November 2016
  25. TAO C, Simpson S Jr, van der Mei I, Blizzard L, et al
    Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Nov 3. pii: jnnp-2016-314013.
    PubMed     Text format     Abstract available


    October 2016
  26. MOROSO A, Ruet A, Lamargue-Hamel D, Munsch F, et al
    Posterior lobules of the cerebellum and information processing speed at various stages of multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Oct 27. pii: jnnp-2016-313867.
    PubMed     Text format     Abstract available


    September 2016
  27. LIZAK N, Lugaresi A, Alroughani R, Lechner-Scott J, et al
    Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Sep 28. pii: jnnp-2016-313976.
    PubMed     Text format     Abstract available


  28. KAWACHI I, Lassmann H
    Neurodegeneration in multiple sclerosis and neuromyelitis optica.
    J Neurol Neurosurg Psychiatry. 2016 Sep 26. pii: jnnp-2016-313300.
    PubMed     Text format     Abstract available


  29. PARDINI M, Sudre CH, Prados F, Yaldizli O, et al
    Relationship of grey and white matter abnormalities with distance from the surface of the brain in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Sep 6. pii: jnnp-2016-313979.
    PubMed     Text format     Abstract available


    August 2016
  30. PAN G, Simpson S Jr, van der Mei I, Charlesworth JC, et al
    Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study.
    J Neurol Neurosurg Psychiatry. 2016 Aug 24. pii: jnnp-2016-313722.
    PubMed     Text format     Abstract available


    June 2016
  31. FAREZ MF
    Salt intake in multiple sclerosis: friend or foe?
    J Neurol Neurosurg Psychiatry. 2016 Jun 27. pii: jnnp-2016-313768.
    PubMed     Text format    


  32. NOURBAKHSH B, Graves J, Casper TC, Lulu S, et al
    Dietary salt intake and time to relapse in paediatric multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Jun 24. pii: jnnp-2016-313410.
    PubMed     Text format     Abstract available


  33. SIMPSON A, Pereira M, Cooper S, Ramagopalan SV, et al
    Seasonality of tweets related to multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Jun 8. pii: jnnp-2016-313941.
    PubMed     Text format    


    May 2016
  34. PATTI F, Messina S, Solaro C, Amato MP, et al
    Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity.
    J Neurol Neurosurg Psychiatry. 2016 May 9. pii: jnnp-2015-312591.
    PubMed     Text format     Abstract available


    April 2016
  35. MOCCIA M, Palladino R, Falco A, Sacca F, et al
    Google Trends: new evidence for seasonality of multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Apr 15. pii: jnnp-2016-313260.
    PubMed     Text format    


  36. WANG C, Beadnall HN, Hatton SN, Bader G, et al
    Automated brain volumetrics in multiple sclerosis: a step closer to clinical application.
    J Neurol Neurosurg Psychiatry. 2016 Apr 12. pii: jnnp-2015-312304.
    PubMed     Text format     Abstract available


    March 2016
  37. WIJNANDS JM, Kingwell E
    Time to wake up and smell the coffee? Coffee consumption and multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Mar 3. pii: jnnp-2015-312431.
    PubMed     Text format    


  38. HEDSTROM AK, Mowry EM, Gianfrancesco MA, Shao X, et al
    High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies.
    J Neurol Neurosurg Psychiatry. 2016 Mar 3. pii: jnnp-2015-312176.
    PubMed     Text format     Abstract available


    February 2016
  39. ZHOVTIS RYERSON L, Frohman TC, Foley J, Kister I, et al
    Extended interval dosing of natalizumab in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Feb 25. pii: jnnp-2015-312940.
    PubMed     Text format     Abstract available


  40. MCGUIGAN C, Craner M, Guadagno J, Kapoor R, et al
    Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group.
    J Neurol Neurosurg Psychiatry. 2016;87:117-25.
    PubMed     Text format     Abstract available


  41. DISANTO G, Adiutori R, Dobson R, Martinelli V, et al
    Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.
    J Neurol Neurosurg Psychiatry. 2016;87:126-9.
    PubMed     Text format     Abstract available


  42. HOEPNER R, Klotz P, Faissner S, Schneider R, et al
    Neuropsychological impairment in natalizumab-associated progressive multifocal leukoencephalopathy: implications for early diagnosis.
    J Neurol Neurosurg Psychiatry. 2016;87:224-6.
    PubMed     Text format    


    December 2015
  43. DOGONOWSKI AM, Blinkenberg M, Paulson OB, Sellebjerg F, et al
    Recovery from an acute relapse is associated with changes in motor resting-state connectivity in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2015 Dec 14. pii: jnnp-2015-311375.
    PubMed     Text format    


    October 2015
  44. MASUDA S, Mori M, Arai K, Uzawa A, et al
    Epstein-Barr virus persistence and reactivation in neuromyelitis optica.
    J Neurol Neurosurg Psychiatry. 2015;86:1137-42.
    PubMed     Text format     Abstract available


    September 2015
  45. HEIDENREICH F
    Long-term treatment of relapsing-remitting multiple sclerosis with interferon beta: how strongly should we encourage patients to adhere to the 'old' therapies?
    J Neurol Neurosurg Psychiatry. 2015 Sep 16. pii: jnnp-2015-310763.
    PubMed     Text format    


  46. KAPPOS L, Kuhle J, Multanen J, Kremenchutzky M, et al
    Factors influencing long-term outcomes in relapsing-remitting multiple sclerosis: PRISMS-15.
    J Neurol Neurosurg Psychiatry. 2015 Sep 15. pii: jnnp-2014-310024.
    PubMed     Text format     Abstract available


    August 2015
  47. SETHI V, Yousry T, Muhlert N, Tozer DJ, et al
    A longitudinal study of cortical grey matter lesion subtypes in relapse-onset multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2015 Aug 13. pii: jnnp-2015-311102.
    PubMed     Text format     Abstract available


  48. MORI M
    Lethal arrhythmia due to fingolimod, a S1P receptor modulator: are we overestimating or underestimating?
    J Neurol Neurosurg Psychiatry. 2015;86:823.
    PubMed     Text format    


    July 2015
  49. WATTJES MP, Vennegoor A, Steenwijk MD, de Vos M, et al
    MRI pattern in asymptomatic natalizumab-associated PML.
    J Neurol Neurosurg Psychiatry. 2015;86:793-8.
    PubMed     Text format     Abstract available


    June 2015
  50. COHEN JA, Khatri B, Barkhof F, Comi G, et al
    Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study.
    J Neurol Neurosurg Psychiatry. 2015 Jun 25. pii: jnnp-2015-310597.
    PubMed     Text format     Abstract available


  51. KOCH MW, Greenfield J, Javizian O, Deighton S, et al
    The natural history of early versus late disability accumulation in primary progressive MS.
    J Neurol Neurosurg Psychiatry. 2015;86:615-21.
    PubMed     Text format     Abstract available


    April 2015
  52. ABSOUD M, Lim MJ, Appleton R, Jacob A, et al
    Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features.
    J Neurol Neurosurg Psychiatry. 2015;86:470-2.
    PubMed     Text format     Abstract available


    March 2015
  53. BAUMANN M, Sahin K, Lechner C, Hennes EM, et al
    Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.
    J Neurol Neurosurg Psychiatry. 2015;86:265-72.
    PubMed     Text format     Abstract available


  54. LALIVE PH, Bridel C, Ferfoglia RI, Kaiser L, et al
    Minimal supportive treatment in natalizumab-related PML in a MS patient.
    J Neurol Neurosurg Psychiatry. 2015;86:354-5.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: